trending Market Intelligence /marketintelligence/en/news-insights/trending/JHY_-0Tl8fEnMorl56hf7w2 content esgSubNav
In This List

Dicerna starts common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Dicerna starts common stock offering

Dicerna Pharmaceuticals Inc. started an underwritten public offering of its common stock.

Net proceeds will be used for preclinical studies and clinical trials, with the remainder being used for continued technology platform development, working capital and general corporate purposes.

Stifel and Evercore ISI are acting as the joint book-running managers for the offering. H.C. Wainwright & Co. and SunTrust Robinson Humphrey are acting as the co-lead managers for the offering.